Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07558395 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour

Study acronym: REVIIH-BT
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion moved earlier from Sep 2029 to Dec 2026
    • Start date: May 15, 2026 to Dec 2026
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 2 of 2 entries
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the efficiency of audiovisual stimulation in virtual reality for improving the visual perception of children, adolescents, and young adults with hemianopia resulting from pediatric brain tumors. These individuals can lose up to 50% of their visual field, significantly impacting their independence, mobility, and daily lives.
Trial Details
NCT Number NCT07558395
Lead Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Collaborators: Fight Kids Cancer
Conditions
(from sponsor)
Hemianopsia, Virtual Reality, Visual Rehabilitation, Pediatric Brain Tumor
Related terms Brain Neoplasms, Hemianopsia
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov